Tuesday, August 12, 2025
6:00PM – 7:00PM ET
Please note this TeleECHO program is 6:00PM Eastern, 5:00PM Central, 4:00PM Mountain and 3:00PM Pacific.
PRESENTING FACULTY
 |
Patricia Kaazan, MD, FRACP Flinders Medical Centre, IBDSA The University of Adelaide Adelaide, South Australia |
PROGRAM OVERVIEW
This program has been designed to enhance learners’ understanding of the complex pathophysiologic relationship linking gut microbiota and inflammation to obesity and inflammatory bowel disease (IBD). Participants will gain insight on the clinical application of findings from pharmacologic trials to optimize the management of patients with obesity and IBD via real word case studies. The program emphasizes a multidisciplinary approach to care, highlighting the identification of negative outcomes linked to obesity and IBD, and promotes the integration of comorbidity awareness into comprehensive patient care plan.
TARGET AUDIENCE
The proposed education will be designed to meet the needs of specialists, including gastroenterologists and gastroenterology nurse practitioners and physician assistants treating patients with IBD and obesity on a global level, except for healthcare providers (HCPs) located in the United Kingdom, who will not be directly targeted (ie, via email or a UK-hosted website) in the targeted HCP reach.
LEARNING OBJECTIVES
Upon completion of this program, attendees should be able to:
- Describe the intricate pathophysiologic interplay between gut inflammation and obesity
- Apply pharmacologic trials findings for both obesity and IBD to optimize care of each concomitantly
- Develop a multidisciplinary team approach to the management of patients with obesity and IBD
- Incorporate an understanding of the comorbidities and negative healthcare outcomes associated with obesity in the IBD patient care plan
JOINT ACCREDITATION STATEMENT
In support of improving patient care, Med Learning Group is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
PHYSICIAN CREDIT DESIGNATION STATEMENT
Med Learning Group designates this virtually live activity for a maximum of 1.0 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the virtually live activity.
NURSES (ANCC) CREDIT DESIGNATION
Med Learning Group designates this activity for a maximum of 1.0 ANCC contact hours.
DISCLOSURE POLICY STATEMENT
In accordance with the Accreditation Council for Continuing Medical Education (ACCME) Standards for Integrity and Independence in Accredited Continuing Education, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff, and planning committee members participating in an MLG-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.
DISCLOSURE OF UNLABELED USE
Med Learning Group requires that faculty participating in any CE activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States. During this lecture, the faculty may mention the use of medications for both FDA-approved and non-approved indications.
DISCLAIMER
Med Learning Group makes every effort to develop CE activities that are science-based. This activity is designed for educational purposes. Participants have a responsibility to use this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making expertise before applying any information, whether provided here or by others, for any professional use.
For CE questions, please contact Med Learning Group at [email protected]
Contact this CE provider at Med Learning Group for privacy and confidentiality policy statement information at www.medlearninggroup.com/privacy-policy/
AMERICANS WITH DISABILITIES ACT
Event staff will be glad to assist you with any special needs (eg, dietary, physical, etc). Please contact Med Learning Group prior to participating at [email protected]
